| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 10.727 | 20.872 | 33.752 | 27.502 | 11.555 | 4.501 | 3.885 | 5.233 |
| Total Income - EUR | - | - | 10.727 | 20.872 | 33.752 | 27.502 | 11.555 | 4.502 | 3.885 | 5.233 |
| Total Expenses - EUR | - | - | 3.413 | 3.981 | 5.212 | 6.800 | 7.539 | 8.505 | 5.264 | 5.789 |
| Gross Profit/Loss - EUR | - | - | 7.314 | 16.891 | 28.540 | 20.702 | 4.016 | -4.003 | -1.379 | -555 |
| Net Profit/Loss - EUR | - | - | 6.992 | 16.265 | 27.527 | 19.937 | 3.711 | -4.138 | -1.379 | -791 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Vitalab Marinca Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 1.523 | 1.068 | 1.470 | 1.581 | 1.189 | 5.825 | 5.651 | 5.464 |
| Current Assets | - | - | 5.651 | 22.840 | 49.041 | 36.267 | 39.850 | 2.462 | 2.255 | 1.908 |
| Inventories | - | - | 0 | 0 | 0 | 176 | 172 | 0 | 0 | 40 |
| Receivables | - | - | 0 | 744 | 1.811 | 33.870 | 34.390 | 1.668 | 2.179 | 1.524 |
| Cash | - | - | 5.651 | 22.096 | 47.230 | 2.221 | 5.288 | 794 | 76 | 343 |
| Shareholders Funds | - | - | 7.036 | 23.172 | 50.250 | 36.157 | 39.066 | -4.090 | -5.457 | -6.217 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 138 | 736 | 262 | 1.692 | 1.973 | 12.377 | 13.363 | 13.589 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Vitalab Marinca Medical Srl